Optimizing the discovery organization for innovation.

Strategic management is the process of adapting organizational structure and management principles to fit the strategic goal of the business unit. The pharmaceutical industry has generally been expert at optimizing its organizations for drug development, but has rarely implemented different structures for the early discovery process, where the objective is innovation and the transformation of innovation into drug projects. Here, a set of strategic management methods is proposed, covering team composition, organizational structure, management principles and portfolio management, which are designed to increase the level of innovation in the early drug discovery process.

[1]  Walter H. Moos,et al.  Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies , 1995 .

[2]  George F. Farris.  The Technical Supervisor: Beyond the Peter Principle , 1974, IEEE Engineering Management Review.

[3]  R. H. Waterman,et al.  In Search of Excellence , 1983 .

[4]  R E Miles,et al.  Organizational strategy, structure, and process. , 1978, Academy of management review. Academy of Management.

[5]  V. Vroom.  Work and motivation , 1964 .

[6]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[7]  G Adler.  When your star performer can't manage. , 1997, Harvard business review.

[8]  Henry Mintzberg,et al.  Of strategies, deliberate and emergent , 1985, Strategic Management Journal.

[9]  Michael Goold,et al.  Strategies and Styles , 1989 .

[10]  Sumit K Chanda,et al.  Fulfilling the promise: drug discovery in the post-genomic era. , 2003, Drug discovery today.

[11]  David F. Horrobin,et al.  Modern biomedical research: an internally self-consistent universe with little contact with medical reality? , 2003, Nature Reviews Drug Discovery.

[12]  R. Stacey.  Strategic Management and Organisational Dynamics: The Challenge of Complexity , 1999 .

[13]  P. Senge.  The leader's new work: Building learning organizations. , 1998 .

[14]  Robert G. Cooper,et al.  Portfolio Management for New Products (Управление портфелем новых продуктов) , 1998 .

[15]  John A. Lowe,et al.  A guide to drug discovery: The role of the medicinal chemist in drug discovery — then and now , 2004, Nature Reviews Drug Discovery.

[16]  Jeffrey S Handen,et al.  The industrialization of drug discovery. , 2002, Drug discovery today.

[17]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[18]  D. Aaker.  Strategic Market Management , 1984 .

[19]  D. Leonard,et al.  Putting your company's whole brain to work. , 1997, Harvard business review.

[20]  M. Schultz,et al.  Informal Collaboration in R & D. The formation of Networks Across Organizations , 1993 .

[21]  Jürgen Drews,et al.  Innovation Deficit in the Pharmaceutical Industry , 1996 .

[22]  M. Tushman,et al.  Readings in the Management of Innovation , 1988 .

[23]  J. Drews.  Stategic trends in the drug industry. , 2003, Drug discovery today.

[24]  G. Superti-Furga,et al.  Rediscovering the sweet spot in drug discovery. , 2003, Drug discovery today.